arrow
J

Junji Koya

National Cancer Center Research Institute
H指数:18
被引数:1,101

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trial

阿特珠单抗治疗复发/难治性结外NK/T细胞淋巴瘤:NCCH1903/ATTACK II期试验

2026-05-220
OAAI
Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors

Saito, Y.; Horie, S.; Kogure, Y.; Mizuno, K.; Ito, Y.; Mizukami, Y.; Kim, H.; Tamura, Z.; Koya, J.; Funakoshi, T.; et al. 高级别实体瘤中全面基因组分析的实时临床应用价值。Nat. Med. 2026, 32, 690–701. [Google Scholar] [CrossRef] [PubMed]

2026-01-060
OAAI
Persistent Unilateral Pleural Effusion with Chimeric Antigen Receptor T-cell Infiltration in Primary Mediastinal Large B-cell Lymphoma

持续性单侧胸腔积液伴嵌合抗原受体T细胞浸润的原发纵隔大B细胞淋巴瘤

2025-10-011
OAAI
In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis

体内CRISPR筛选揭示了KMT2D和TP53缺陷在B细胞淋巴瘤发生中的协同作用

2025-07-210
OAAI
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma

TP53和CDKN2A的异常改变定义了结节性T滤泡辅助细胞淋巴瘤患者中一个预后不良的亚群。

LEUKEMIA
IF13.4
2025-05-020
PRE
Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenvironmental changes and identifies therapeutic targets
2024-10-220
OAAI
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma
2024-04-242
PRE
Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
2023-02-169
OAAI
CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma
2022-11-295
OAAI
Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
2021-07-1314
OAAI